These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6306224)

  • 1. Tissue angiotensin converting enzyme inhibition as an index of the disposition of enalapril (MK-421) and metabolite MK-422.
    Cohen ML; Kurz KD; Schenck KW
    J Pharmacol Exp Ther; 1983 Jul; 226(1):192-6. PubMed ID: 6306224
    [No Abstract]   [Full Text] [Related]  

  • 2. Enalapril maleate (MK-421), a potent, nonsulfhydryl angiotensin-converting enzyme inhibitor: absorption, disposition, and metabolism in man.
    Ulm EH
    Drug Metab Rev; 1983; 14(1):99-110. PubMed ID: 6301792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition of enalapril and its diacid metabolite, enalaprilat, in a perfused rat liver preparation. Presence of a diffusional barrier for enalaprilat into hepatocytes.
    Pang KS; Cherry WF; Terrell JA; Ulm EH
    Drug Metab Dispos; 1984; 12(3):309-13. PubMed ID: 6145558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of antihypertensive effect of enalapril to serum MK-422 levels and angiotensin converting enzyme inhibition.
    Johnston CI; Jackson B; McGrath B; Matthews G; Arnolda L
    J Hypertens Suppl; 1983 Oct; 1(1):71-5. PubMed ID: 6100611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin converting enzyme activity in human serum: relationship to enzyme inhibitor in vivo and in vitro.
    Swanson BN; Hichens M; Mojaverian P; Ferguson RK; Vlasses PH; Dudash M
    Res Commun Chem Pathol Pharmacol; 1981 Sep; 33(3):525-36. PubMed ID: 6276950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422.
    Cascieri MA; Bull HG; Mumford RA; Patchett AA; Thornberry NA; Liang T
    Mol Pharmacol; 1984 Mar; 25(2):287-93. PubMed ID: 6199659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril.
    Udupa EG; Rao NM
    Indian J Biochem Biophys; 1997 Dec; 34(6):524-8. PubMed ID: 9594434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Captopril and MK-421: stability on storage, distribution to the central nervous system, and onset of activity.
    Cohen ML; Kurz K
    Fed Proc; 1983 Feb; 42(2):171-5. PubMed ID: 6295820
    [No Abstract]   [Full Text] [Related]  

  • 9. The physiological disposition and metabolism of enalapril maleate in laboratory animals.
    Tocco DJ; deLuna FA; Duncan AE; Vassil TC; Ulm EH
    Drug Metab Dispos; 1982; 10(1):15-9. PubMed ID: 6124377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CI-906 and CI-907: new orally active nonsulfhydryl angiotensin-converting enzyme inhibitors.
    Kaplan HR; Cohen DM; Essenburg AD; Major TC; Mertz TE; Ryan MJ
    Fed Proc; 1984 Apr; 43(5):1326-9. PubMed ID: 6323223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chemistry of enalapril.
    Patchett AA
    Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):201S-207S. PubMed ID: 6085275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological and pharmacological aspects of angiotensin converting enzyme.
    Fyhrquist F; Grönhagen-Riska C; Forslund T; Hortling L
    Scand J Urol Nephrol Suppl; 1984; 79():39-43. PubMed ID: 6089317
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of idrapril calcium on tissue angiotensin-converting enzyme in rats.
    Becagli P; Lippi A; Criscuoli M; Breschi MC; Subissi A
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):27-32. PubMed ID: 7564361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human angiotensin I competes with two non-thiol converting enzyme inhibitors (CGS 13934 & MK-422) to inhibit the angiotensin-converting enzyme activity of human plasma.
    Chen DS; Nussberger J; Brunner HR; Waeber B
    J Pharm Pharmacol; 1984 Oct; 36(10):707-8. PubMed ID: 6150096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme.
    Grinshtein SV; Binevski PV; Gomazkov OA; Pozdnev VF; Nikolskaya II; Kost OA
    Biochemistry (Mosc); 1999 Aug; 64(8):938-44. PubMed ID: 10498812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Angiotensin converting enzyme].
    Kokubu T; Takada Y
    Nihon Rinsho; 1982; 40(9):1956-63. PubMed ID: 6296486
    [No Abstract]   [Full Text] [Related]  

  • 17. Measurement of low angiotensin concentrations after ethanol and Dowex extraction procedures.
    Nussberger J; Brunner DB; Waeber B; Brunner HR
    J Lab Clin Med; 1984 Feb; 103(2):304-12. PubMed ID: 6319516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enalpril (MK-421) induced attenuation of norepinephrine induced responses in isolated perfused rat mesentery.
    Gulati N; Huggel H; Gulati OP
    Indian J Exp Biol; 1984 Jan; 22(1):57-8. PubMed ID: 6086508
    [No Abstract]   [Full Text] [Related]  

  • 19. Enalapril, a new nonsulfhydryl angiotensin converting enzyme inhibitor, does not potentiate morphine analgesia.
    Mojaverian P; Swanson BN; Ferguson RK
    Eur J Pharmacol; 1984 Feb; 98(2):303-6. PubMed ID: 6325220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total serum angiotensin converting enzyme activity in rats and dogs after enalapril maleate (MK-421).
    Ulm EH; Vassil TC
    Life Sci; 1982 Apr; 30(14):1225-30. PubMed ID: 6283285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.